We are delighted to present the 2024 Annual Report of Mediastinum. The journal has continued to build on its international editorial board, diverse authorship and readership, steady publication volume, and significant […]
Abstract Book for the 14th International Thymic Malignancy Interest Group Annual Meeting (ITMIG 2024) is now available in MEDIASTINUM. The Best Abstract on Thymic Carcinoma Study Submitted to ITMIG2024 Annual […]
Volume 12 Welcome to this new edition of our ITMIG Newsletter summarizing the society’s activity over the past year. Committees ITMIG Committees are the core of our society, and […]
The ITMIG database is a major resource for studying the characteristics, treatment strategies, and outcomes of patients with thymic malignancies. More than 2000 patients are enrolled. The database is open […]
Kaminski HJ et al. Abstract The role of immunosenescence, particularly the natural process of thymic involution during aging, is increasingly acknowledged as a factor contributing to the development of autoimmune […]
We proudly announce that since May 22, 2024, Mediastinum has become the official journal of the International Thymic Malignancy Interest Group! This represents a collaborative partnership between two institutions with […]
It is with profound sadness that ITMIG announces the passing of Professor Hans Konrad Müller-Hermelink on May 11th, 2024. Professor Müller-Hermelink was a distinguished expert in the study of […]
ITMIG is a multidisciplinary group currently consisting of surgeons, pathologists, imaging specialists, oncologists, and neurologists, aiming for better management of patients with thymic tumors through an optimized interaction between the […]
We present a recording of a lecture by Professor Enrico Ruffini (University of Turin, Torino, Italy) on the changes we can expect in the 9th Edition of the TNM classification […]
The following is an invitation sent by Laura Abate-Daga to a webinar for thymic tumor patient organized by Italian patient society – TUTOR: On the 16th of November, 2023 at […]